Evaxion Biotech (EVAX) Tops Q1 EPS by 8c

Evaxion Biotech (NASDAQ: EVAX) reported Q1 EPS of ($0.25), $0.08 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• RBC bullish on Kraft Heinz, sees return to growth in 2027
• Gartner places F5 in AI application security emerging market report